Innovative regenerative implants manufacturer Osteopore Limited announced the commencement of a study with Singular Health Group to improve the efficiency and accuracy of Ostepore’s cranial implants.
Osteopore develops its customised implants using patients’ CT scans provided by surgeons. A software processes the scans that convert them into 3D models, which can be used to 3D print customised implants. The goal of Singular Health’s AI engine is to lessen modeling time while improving design accuracy.
Singular Health has worked to evolve its design engine through a project with CSIRO Data61 since signing a memorandum of understanding in October 2021. The results from this joint project have enabled the design of a cranial implant in less than four minutes with 91% accuracy.
With these results, Singular Health and Ostepore will conduct a comparative study to collate empirical data that will develop a pathway to full FDA approval for AI model and deployment in Ostepore cranial applications. This study will verify the efficiency and accuracy of the AI-model and Singular Health’s 3Dicom Surgical software compared to Osteopore’s existing workflow.
Expected results include improved implant quality and a reduction in product-to-customer timeframes. The study is a part of Osteopore’s sustainable growth plan, which involves improvements in the workflow to provide better products and services to customers.
“I am delighted to have this opportunity to work with Singular Health to provide them 40 CT scans to train the AI algorithm to recognise skull defects and construct design to fill the defect. The result is remarkable, with a user-friendly interface to assist surgeons in constructing a design to fill the defect. We look forward to a potential commercial outcome between the two companies.” Osteopore CEO Goh Khoon Seng said.
“The future of data processing for accurate implant design is here, and Osteopore is excited to be at the leading edge of this development. We look forward to the outcomes of the comparative study and to an impactful outcome for our process and customers.” Osteopore Chief Technology Officer Lim Jing stated.
According to Singular Health CEO Thomas Hanly:
“Working with Osteopore on this project provided our team with the ability to focus our research on a commercial outcome. Singular has worked closely with both the CSIRO and Osteopore and this collaborative outcome demonstrates the ability of AI to accelerate the manual processes in the Scan to Surgery workflow. I now look forward to working closely with Osteopore in commercialising our software through their global client network.”
Image Source: www.facebook.com/Osteopore
